Arena Pharmaceuticals, Inc. (ARNA) Misses Q1 EPS by 2c

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q1 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $6.8 million versus the consensus estimate of $7.98 million.

For earnings history and earnings-related data on Arena Pharmaceuticals, Inc. (ARNA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Vivos Therapeutics posts 35% revenue gain but widens net loss
• Cisco rating cut at HSBC as analyst sees a lack of catalysts